SCHEMBL362875

SCHEMBL362875

C=Nc1c(F)cc(F)cc1F

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
ALDH1A1 P00352 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA9 Q16790 1/20 0.30
ERN1 O75460 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636241 0.75 ERN1 (0.37) CES2CES1ALDH1A1CA12CA1
SCHEMBL5881043 0.75 ERN1 (0.37) CES2CES1ALDH1A1CA12CA1
SCHEMBL3194530 0.75 CES2 (0.35) CES2CES1ALDH1A1CA12CA1
SCHEMBL363206 0.71 CES2 (0.36) CES2CES1ALDH1A1ERN1
SCHEMBL9606815 0.71 CES2 (0.37) CES2CES1ALDH1A1CA12CA1
SCHEMBL19014837 0.70 HPGD (0.35) CA12CA9
SCHEMBL364041 0.69 IDO1 (0.33)
SCHEMBL457203 0.65 GABRA1 (0.34)
SCHEMBL11883312 0.65 PLAU (0.44) CES2CES1ALDH1A1CA12CA1
SCHEMBL160448 0.65 GABRA1 (0.35) CES2CES1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2311112-B1 ELECTRONIC DEVICES COMPRISING METAL COMPLEXES HAVING ISONITRILE LIGANDS MERCK PATENT GMBH (DE) 2012-03-14 EP disclosed
US-20110101327-A1 Electronic Devices Comprising Metal Complexes Having Isonitrile Ligands MERCK PATENT GMBH (DE) 2011-05-05 US disclosed
WO-2010015307-A1 ELECTRONIC DEVICES COMPRISING METAL COMPLEXES HAVING ISONITRILE LIGANDS MERCK PATENT GMBH (DE) 2010-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110101327-A1 Electronic Devices Comprising Metal Complexes Having Isonitrile Ligands EXOC4, ICMT, NCLN CES2 2721/4885CES1 4833/4885ALDH1A1 2323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.